Of note, Sglt2 but not Sglt1 gene expression was increased in diabetes, whereas treatment with dapagliflozin decreased both Sglt2 and Sglt1 expression (Figure S1I). This evidence concerns the gene SLC5A2 and diabetes mellitus.